Impact of a drug utilization review program on high-risk use of prescription controlled substances
Version of Record online: 24 JUL 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 4, pages 419–427, April 2014
How to Cite
Daubresse, M., Gleason, P. P., Peng, Y., Shah, N. D., Ritter, S. T. and Alexander, G. C. (2014), Impact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidem. Drug Safe., 23: 419–427. doi: 10.1002/pds.3487
- Issue online: 5 APR 2014
- Version of Record online: 24 JUL 2013
- Manuscript Accepted: 25 JUN 2013
- Manuscript Revised: 9 APR 2013
- Manuscript Received: 21 DEC 2012
- Agency for Healthcare Research and Quality. Grant Number: RO1 HS0189960
Appendix 1. Prescription drugs by DEA schedule
|pds3487-sup-0001-appendixS1.docx||Word 2007 document||62K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.